Personalized Medicine Market Exhibiting Exhilarant Prospective
Backed by factors, such as early detection of diseases and optimization of therapies, the US market for personalized medicine is likely to register a CAGR of 12% during 2009-2015, says a report by RNCOS.
View full press release